Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 66

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 66
---
 |

Fees and Expenses

The following table shows the
per share and accompanying warrant and per pre-funded warrant and accompanying warrant and
total placement agent fees we will pay in connection with the sale of the securities in this offering.

|                      |     | Per Share and Accompanying Warrant |       |     | Per Pre-Funded Warrant and Accompanying Warrant |       |     | Total |         |
|:---------------------|:----|:-----------------------------------|------:|:----|:------------------------------------------------|------:|:----|:------|--------:|
| Placement Agent Fees |     | $                                  | 0.056 |     | $                                               | 0.056 |     | $     | 281,250 |

We have agreed to pay the placement
agent a cash fee equal to 6.25% of the gross proceeds raised at the closing of this offering. We also agreed to issue warrants to the
placement agent for the purchase of a number of shares of common stock equal to 4% of the total number of shares of common stock issued
in this offering. In addition, we have agreed to reimburse the placement agent for its legal fees and expenses and other out-of-pocket
expenses in an amount up to $100,000. We estimate the total offering expenses of this offering that will be payable by us, excluding the
placement agent fees and expenses, will be approximately $282,500.

Placement Agent Warrants

In
addition, we have agreed to issue to the placement agent or its designees warrants to purchase up to 200,000 shares of common stock (which
represents 4% of the aggregate number of shares of common stock issued in this offering) with an exercise price of $0.90 per share (representing
100% of the combined public offering price per share of common stock (or pre-funded warrant) and accompanying warrant in this offering).
The placement agent warrants will be non-exercisable for six (6) months after the date of the closing and will expire five years after
the commencement of sales of the offering. The form of the placement agent warrants has been included as an exhibit to this registration
statement of which this prospectus is a part.

Lock-up Agreements

We have agreed with the placement
agent to be subject to a lock-up period of 90 days following the date of closing of the offering pursuant to this prospectus.
Each of our officers and directors have agreed with the placement agent to be subject to a